This topic contains a solution. Click here to go to the answer

Author Question: Cones in the retina: a. Distinguish among different wavelengths b. Are more sensitive to light ... (Read 92 times)

B

  • Hero Member
  • *****
  • Posts: 570
Cones in the retina:
 
  a. Distinguish among different wavelengths
  b. Are more sensitive to light than rods
  c. Provide the poorest visual acuity
  d. Are most numerous at the periphery of the retina

Question 2

Obesity in rodents can result from being:
 
  a. Homozygous for the recessive obesity gene
  b. Homozygous for the diabetes gene
  c. Heterozygous for the diabetes gene
  d. Homozygous for the dominant obesity gene



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

vish98

  • Sr. Member
  • ****
  • Posts: 326
Answer to Question 1

A

Answer to Question 2

A




B

  • Member
  • Posts: 570
Reply 2 on: Jun 22, 2018
YES! Correct, THANKS for helping me on my review


meganmoser117

  • Member
  • Posts: 303
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

It is important to read food labels and choose foods with low cholesterol and saturated trans fat. You should limit saturated fat to no higher than 6% of daily calories.

Did you know?

Increased intake of vitamin D has been shown to reduce fractures up to 25% in older people.

Did you know?

Carbamazepine can interfere with the results of home pregnancy tests. If you are taking carbamazepine, do not try to test for pregnancy at home.

Did you know?

Stevens-Johnson syndrome and Toxic Epidermal Necrolysis syndrome are life-threatening reactions that can result in death. Complications include permanent blindness, dry-eye syndrome, lung damage, photophobia, asthma, chronic obstructive pulmonary disease, permanent loss of nail beds, scarring of mucous membranes, arthritis, and chronic fatigue syndrome. Many patients' pores scar shut, causing them to retain heat.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library